Gulf International Bank UK Ltd Trims Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Gulf International Bank UK Ltd decreased its position in Henry Schein, Inc. (NASDAQ:HSICFree Report) by 3.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 10,494 shares of the company’s stock after selling 332 shares during the quarter. Gulf International Bank UK Ltd’s holdings in Henry Schein were worth $765,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in shares of Henry Schein by 1.7% during the first quarter. Vanguard Group Inc. now owns 15,432,001 shares of the company’s stock valued at $1,165,425,000 after buying an additional 260,537 shares during the period. American Century Companies Inc. lifted its position in Henry Schein by 3.1% during the second quarter. American Century Companies Inc. now owns 5,484,286 shares of the company’s stock worth $351,543,000 after buying an additional 162,477 shares during the period. Swedbank AB acquired a new stake in Henry Schein in the 1st quarter worth about $215,998,000. Nuance Investments LLC increased its stake in shares of Henry Schein by 6.2% during the 2nd quarter. Nuance Investments LLC now owns 1,863,333 shares of the company’s stock valued at $119,440,000 after acquiring an additional 108,143 shares during the last quarter. Finally, Burgundy Asset Management Ltd. lifted its holdings in shares of Henry Schein by 1.0% during the 2nd quarter. Burgundy Asset Management Ltd. now owns 1,640,379 shares of the company’s stock worth $105,148,000 after acquiring an additional 16,476 shares during the period. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research firms have weighed in on HSIC. JPMorgan Chase & Co. cut their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research note on Monday, August 12th. UBS Group dropped their price target on Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a research note on Thursday. Robert W. Baird decreased their target price on Henry Schein from $92.00 to $82.00 and set an “outperform” rating for the company in a report on Wednesday, August 7th. Finally, Baird R W upgraded shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $77.50.

View Our Latest Analysis on Henry Schein

Henry Schein Price Performance

Shares of NASDAQ HSIC opened at $68.00 on Friday. The business’s fifty day moving average price is $70.51 and its two-hundred day moving average price is $69.75. Henry Schein, Inc. has a 1-year low of $62.12 and a 1-year high of $82.63. The firm has a market capitalization of $8.62 billion, a PE ratio of 27.98, a P/E/G ratio of 2.00 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.90.

Henry Schein (NASDAQ:HSICGet Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion for the quarter, compared to the consensus estimate of $3.24 billion. During the same quarter in the previous year, the business earned $1.32 EPS. The company’s quarterly revenue was up .4% compared to the same quarter last year. On average, research analysts expect that Henry Schein, Inc. will post 4.76 EPS for the current year.

Insider Buying and Selling

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now directly owns 71,833 shares in the company, valued at approximately $4,978,026.90. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

(Free Report)

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Articles

Institutional Ownership by Quarter for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.